10-Q: Verano Holdings Reports Q1 2025 Results: Revenue Declines Amid Increased Competition
Quarterly Report
Verano Holdings Corp. reports a decrease in revenue for Q1 2025, primarily due to increased competition and promotional activities in key markets.
Summary
- Verano Holdings Corp. reported a net revenue of $209.81 million for the three months ended March 31, 2025, a 5.2% decrease compared to $221.31 million for the same period in 2024.
- The decrease in revenue is attributed to increased competition and promotional activity, particularly in New Jersey and Illinois.
- The company experienced a net loss of $11.52 million, compared to a net loss of $4.82 million in the prior year.
- Gross profit decreased to $99.58 million, with a gross profit margin of 47.5%, down from 51.0% in Q1 2024.
- Selling, general, and administrative expenses decreased by 6.3% to $84.58 million.
- The company opened two new stores during the quarter, one in Connecticut and one in Florida.
- As of May 5, 2025, Verano operates in 13 states with 155 retail dispensaries and 15 production facilities.
- The company's capital expenditure guidance for the year-ended December 31, 2025 is in the range of $30 million to $45 million.
Sentiment
Score: 4
Explanation: The sentiment is slightly negative due to decreased revenue and increased net loss, although there are some positive aspects like reduced SG&A expenses and new store openings. The overall tone suggests challenges in the current market environment.
Positives
- Selling, general, and administrative expenses decreased by 6.3% year-over-year.
- The company opened two new stores, expanding its retail footprint.
- Verano is focusing on efficiency enhancements at its cultivation and processing facilities.
- The company reported a gain on deconsolidation of its Arkansas operations of $4.739 million.
Negatives
- Revenue decreased by 5.2% compared to the same quarter last year.
- Net loss increased from $4.82 million to $11.52 million.
- Gross profit margin decreased from 51.0% to 47.5%.
- The company cited increased competition and promotional activity as factors impacting revenue.
Risks
- The cannabis industry remains illegal under U.S. federal law, posing potential legal and financial risks.
- Changes in U.S. trade policy, including tariffs, could increase costs and disrupt the supply chain.
- Increased competition and promotional activity in key markets are impacting revenue and margins.
- The company is subject to Section 280E of the U.S. Internal Revenue Code, which limits deductions.
- Ongoing litigation with Vireo Growth Inc. could have a material adverse effect.
Future Outlook
The company expects to focus on efficiency enhancements at its cultivation and processing facilities and strategic expansion of its retail footprint, with capital expenditures guided between $30 million and $45 million for 2025.
Industry Context
The report indicates increased competition and promotional activity in key markets like New Jersey and Illinois, which is consistent with trends observed among other multi-state cannabis operators.
Comparison to Industry Standards
- The report mentions increased competition and promotional activity in select retail markets, specifically in New Jersey and Illinois which is consistent with other multi-state cannabis operators.
- Without specific data on competitors like Curaleaf, Trulieve, or Green Thumb Industries, a direct comparison of revenue growth and profitability is difficult.
- However, the challenges cited by Verano, such as pricing pressure and increased competition, are common across the cannabis industry.
Management Changes
| Role | Previous Person | New Person | Effective Date | Reason |
|---|---|---|---|---|
| Chief Financial Officer | Brett Summerer | Richard Tarapchak | April 11, 2025 | Resignation |
Legal Proceedings
- The company is involved in ongoing litigation with Vireo Growth Inc. (formerly Goodness Growth Holdings, Inc.) related to a terminated arrangement agreement.
Related Party Transactions
- George Archos, the Chairman and Chief Executive Officer of the Company, participated in the 2022 Credit Agreement as a lender funding $1,000 of the original $350,000 principal amount.
- The Company leases real property for a retail dispensary in Aurora, Illinois from 740 Rte. 59, LLC, where George Archos holds an indirect 50% ownership interest.
- The Company leases real property for a retail dispensary in Lombard, Illinois from 783 Butterfield LLC, where George Archos holds a 50% indirect ownership interest.
- GP Management Group, LLC, an entity beneficially owned and controlled by George Archos, the Company's Chief Executive Officer, held an ownership interest of less than 1% in Sweed as of March 31, 2025.
Stakeholder Impact
- Shareholders may be concerned about the decrease in revenue and increase in net loss.
- Employees may be affected by potential efficiency enhancements and strategic shifts.
- Customers may experience changes in promotional activity and product availability.
- Suppliers may see adjustments in procurement strategies.
Next Steps
- The company will focus on efficiency enhancements at its cultivation and processing facilities.
- The company will strategically expand its retail footprint.
Key Dates
| Date | Description |
|---|---|
| February 27, 2025 | Filing of Annual Report on Form 10-K for the fiscal year ended December 31, 2024 |
| March 14, 2025 | Company entered into a loan with Rainbow Realty Group IV, LLC for $12 million. |
| March 31, 2025 | End of the quarterly period |
| April 11, 2025 | Richard Tarapchak appointed as Chief Financial Officer, effective as of this date. |
| April 14, 2025 | Brett Summerer resigned as Chief Financial Officer of the Company. |
| May 5, 2025 | Date as of which the company operates in 13 states with 155 retail dispensaries and 15 production facilities. |
| May 8, 2025 | Date of report filing |
Keywords
Verano Holdings, cannabis, financial results, Q1 2025, revenue, net loss, gross profit, dispensaries, cultivation, retail, 280E, competition
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.